Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioregenx (BRGX) Return on Equity (2022 - 2025)

Bioregenx has reported Return on Equity over the past 4 years, most recently at 0.0% for Q4 2025.

  • For Q4 2025, Return on Equity rose 4.0% year-over-year to 0.0%; the TTM value through Dec 2025 reached 0.0%, up 4.0%, while the annual FY2025 figure was 0.0%, 8.0% down from the prior year.
  • Return on Equity for Q4 2025 was 0.0% at Bioregenx, down from 0.05% in the prior quarter.
  • Over five years, Return on Equity peaked at 0.06% in Q1 2025 and troughed at 0.04% in Q4 2024.
  • A 4-year average of 0.01% and a median of 0.0% in 2023 define the central range for Return on Equity.
  • Biggest five-year swings in Return on Equity: fell -4bps in 2024 and later rose 6bps in 2025.
  • Year by year, Return on Equity stood at 0.0% in 2022, then surged by 584bps to 0.0% in 2023, then plummeted by -1129bps to 0.04% in 2024, then soared by 109bps to 0.0% in 2025.
  • Business Quant data shows Return on Equity for BRGX at 0.0% in Q4 2025, 0.05% in Q3 2025, and 0.05% in Q2 2025.